vs

Side-by-side financial comparison of Enact Holdings, Inc. (ACT) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Enact Holdings, Inc. is the larger business by last-quarter revenue ($312.7M vs $194.7M, roughly 1.6× Vertex, Inc.). On growth, Vertex, Inc. posted the faster year-over-year revenue change (9.1% vs 3.6%). Over the past eight quarters, Vertex, Inc.'s revenue compounded faster (11.4% CAGR vs 3.6%).

Enact Holdings, Inc. is a leading U.S.-based private mortgage insurance provider. It delivers risk mitigation solutions to residential mortgage lenders, banks, and credit unions, enabling borrowers with smaller down payments to access affordable home financing, and supports sustainable homeownership for diverse consumer groups across the United States.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

ACT vs VERX — Head-to-Head

Bigger by revenue
ACT
ACT
1.6× larger
ACT
$312.7M
$194.7M
VERX
Growing faster (revenue YoY)
VERX
VERX
+5.5% gap
VERX
9.1%
3.6%
ACT
Faster 2-yr revenue CAGR
VERX
VERX
Annualised
VERX
11.4%
3.6%
ACT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACT
ACT
VERX
VERX
Revenue
$312.7M
$194.7M
Net Profit
$-7.0M
Gross Margin
64.8%
Operating Margin
71.3%
-1.3%
Net Margin
-3.6%
Revenue YoY
3.6%
9.1%
Net Profit YoY
89.7%
EPS (diluted)
$1.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACT
ACT
VERX
VERX
Q4 25
$312.7M
$194.7M
Q3 25
$311.5M
$192.1M
Q2 25
$304.9M
$184.6M
Q1 25
$306.8M
$177.1M
Q4 24
$301.8M
$178.5M
Q3 24
$309.6M
$170.4M
Q2 24
$298.8M
$161.1M
Q1 24
$291.6M
$156.8M
Net Profit
ACT
ACT
VERX
VERX
Q4 25
$-7.0M
Q3 25
$4.0M
Q2 25
$-961.0K
Q1 25
$11.1M
Q4 24
$-67.8M
Q3 24
$7.2M
Q2 24
$5.2M
Q1 24
$2.7M
Gross Margin
ACT
ACT
VERX
VERX
Q4 25
64.8%
Q3 25
63.1%
Q2 25
65.7%
Q1 25
63.8%
Q4 24
65.6%
Q3 24
64.8%
Q2 24
63.7%
Q1 24
61.1%
Operating Margin
ACT
ACT
VERX
VERX
Q4 25
71.3%
-1.3%
Q3 25
67.4%
2.2%
Q2 25
70.4%
-2.1%
Q1 25
68.9%
2.5%
Q4 24
68.9%
-7.3%
Q3 24
74.1%
2.9%
Q2 24
78.6%
4.7%
Q1 24
70.6%
-1.0%
Net Margin
ACT
ACT
VERX
VERX
Q4 25
-3.6%
Q3 25
2.1%
Q2 25
-0.5%
Q1 25
6.3%
Q4 24
-38.0%
Q3 24
4.2%
Q2 24
3.2%
Q1 24
1.7%
EPS (diluted)
ACT
ACT
VERX
VERX
Q4 25
$1.23
Q3 25
$1.10
Q2 25
$1.11
Q1 25
$1.08
Q4 24
$1.05
Q3 24
$1.15
Q2 24
$1.16
Q1 24
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACT
ACT
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$582.5M
$314.0M
Total DebtLower is stronger
$744.5M
$337.5M
Stockholders' EquityBook value
$5.4B
$258.9M
Total Assets
$6.9B
$1.3B
Debt / EquityLower = less leverage
0.14×
1.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACT
ACT
VERX
VERX
Q4 25
$582.5M
$314.0M
Q3 25
$545.6M
$313.5M
Q2 25
$616.0M
$284.4M
Q1 25
$639.0M
$270.4M
Q4 24
$602.8M
$296.1M
Q3 24
$674.9M
$279.0M
Q2 24
$711.3M
$325.5M
Q1 24
$624.3M
$56.1M
Total Debt
ACT
ACT
VERX
VERX
Q4 25
$744.5M
$337.5M
Q3 25
$744.1M
$336.9M
Q2 25
$743.8M
$336.3M
Q1 25
$743.4M
$335.8M
Q4 24
$743.0M
$335.2M
Q3 24
$742.7M
$334.7M
Q2 24
$742.4M
$334.1M
Q1 24
$746.1M
$46.0M
Stockholders' Equity
ACT
ACT
VERX
VERX
Q4 25
$5.4B
$258.9M
Q3 25
$5.3B
$264.5M
Q2 25
$5.2B
$248.0M
Q1 25
$5.1B
$200.5M
Q4 24
$5.0B
$179.4M
Q3 24
$5.0B
$259.0M
Q2 24
$4.8B
$233.1M
Q1 24
$4.7B
$250.1M
Total Assets
ACT
ACT
VERX
VERX
Q4 25
$6.9B
$1.3B
Q3 25
$6.9B
$1.2B
Q2 25
$6.8B
$1.2B
Q1 25
$6.7B
$1.2B
Q4 24
$6.5B
$1.2B
Q3 24
$6.6B
$1.2B
Q2 24
$6.3B
$1.0B
Q1 24
$6.3B
$755.8M
Debt / Equity
ACT
ACT
VERX
VERX
Q4 25
0.14×
1.30×
Q3 25
0.14×
1.27×
Q2 25
0.14×
1.36×
Q1 25
0.15×
1.67×
Q4 24
0.15×
1.87×
Q3 24
0.15×
1.29×
Q2 24
0.15×
1.43×
Q1 24
0.16×
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACT
ACT
VERX
VERX
Operating Cash FlowLast quarter
$724.5M
$42.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACT
ACT
VERX
VERX
Q4 25
$724.5M
$42.3M
Q3 25
$192.0M
$62.5M
Q2 25
$119.5M
$46.0M
Q1 25
$226.7M
$14.8M
Q4 24
$686.3M
$41.1M
Q3 24
$188.1M
$41.4M
Q2 24
$144.7M
$57.7M
Q1 24
$187.3M
$24.6M
Free Cash Flow
ACT
ACT
VERX
VERX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-24.3M
Q2 24
Q1 24
$10.1M
FCF Margin
ACT
ACT
VERX
VERX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-14.2%
Q2 24
Q1 24
6.5%
Capex Intensity
ACT
ACT
VERX
VERX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
38.5%
Q2 24
Q1 24
9.2%
Cash Conversion
ACT
ACT
VERX
VERX
Q4 25
Q3 25
15.44×
Q2 25
Q1 25
1.33×
Q4 24
Q3 24
5.73×
Q2 24
11.18×
Q1 24
9.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACT
ACT

Segment breakdown not available.

VERX
VERX

Cloud Subscriptions$94.6M49%
Software Licenses$71.6M37%
Service Other$28.5M15%

Related Comparisons